NRG starts process for new reactor

Nov 19, 2009

Dutch radiopharmaceutical producer Nuclear Research and Consultancy Group (NRG) has begun the regulatory approval process to build a nuclear reactor to replace its High Flux Reactor (HFR) in Petten, Netherlands.

NRG this week submitted an application for an environmental impact assessment report to the Dutch Ministry of Housing, Spatial Planning, and the Environment for the Pallas reactor.

The submission is the first step in a process to request a permit for the construction of a new research reactor to produce isotopes for medical applications and expand scientific and applied nuclear research.

NRG is considering two locations for Pallas: Petten in the northwest region of North Holland and Borssele in the southwest region of Zeeland.

The goal is to have Pallas operating in 2016, pending funding and regulatory approvals.

Petten reactor set for July 18 shutdown, July 10, 2009

Petten nuclear reactor to restart, February 12, 2009

NRCG reactor will be down longer, December 22, 2008

Belgium to restart medical isotope production, November 5, 2008

$ChatGPT powered by GPT-4 and using DALL-E−3 was asked to generate an image for teaching purposes that demonstrated: a nuclear medicine bone scan with skeletal metastases (top left); coronary artery disease (top right); an F-18 FDG-PET scan of the brain with Alzheimer's disease (bottom left); and an x-ray showing a fracture (bottom right). These are misleading for educational purposes and for patients who may be searching for information. Image and caption courtesy of Radiography.$